Evolus hits over two-month high, raises 2023 revenue outlook

Evolus

27/07/2023 15:55

** Shares of medical aesthetic company Evolus Inc  EOLS.O 
rise 25.8% to $9.8, hitting an over two-month high
    ** Co raises FY23 net revenue forecast to $185 mln to $195
mln vs previous view of $180 mln to $190 mln
    ** Posts Q2 net revenue of $49.3 mln vs analysts' estimates
of $47.5 mln 
    ** Co benefited from accelerated growth momentum of Jeuveau,
an injection used for the treatment of wrinkles
    ** Stock up 32.2% YTD

 (Reporting by Sruthi Narasimha Chari in Bengaluru)
 ((Sruthinarasimha.chari@thomsonreuters.com))